SCHEMBL7484113

SCHEMBL7484113

CCN=C=NC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4275672 0.97
SCHEMBL9074979 0.92 CYP1A2 (0.38)
Dimethylamine SCHEMBL8019309 0.85 CYP1A2 (0.34)
SCHEMBL8019299 0.84 CYP1A2 (0.35)
Methacrylic Acid SCHEMBL26108796 0.79
SCHEMBL287060 0.78
SCHEMBL25895367 0.78
SCHEMBL6469505 0.78 CYP1A2 (0.32)
Hydrochloric Acid SCHEMBL6255561 0.76 CYP1A2 (0.31)
SCHEMBL8019304 0.75 CYP1A2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024171668-A1 PRETREATMENT LIQUID FOR INKJET INK, INK SET, IMAGE RECORDING METHOD, LAMINATE MANUFACTURING METHOD, IMAGE RECORDED MATTER, AND LAMINATE 富士フイルム株式会社 2024-08-22 WO disclosed
US-11739074-B2 Ras inhibitors Revolution Medicines, Inc. (US) 2023-08-29 US disclosed
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 US disclosed
WO-2021132235-A1 ADHESIVE COMPOSITION 住友化学株式会社 2021-07-01 WO disclosed
US-20210130326-A1 RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2021-05-06 US disclosed
US-10913754-B2 Lanthanum compound and methods of forming thin film and integrated circuit device using the lanthanum compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-02-09 US disclosed
US-10913754-B2 Lanthanum compound and methods of forming thin film and integrated circuit device using the lanthanum compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-02-09 US disclosed
WO-2020031830-A1 RESIN AND PRESSURE-SENSITIVE ADHESIVE COMPOSITION 住友化学株式会社 2020-02-13 WO disclosed
US-20190152996-A1 LANTHANUM COMPOUND AND METHODS OF FORMING THIN FILM AND INTEGRATED CIRCUIT DEVICE USING THE LANTHANUM COMPOUND ADEKA CORPORATION (JP) 2019-05-23 US disclosed
EP-2592120-B1 AQUEOUS INKJET INK, AND METHOD FOR FORMING INKJET IMAGE KONICA MINOLTA HOLDINGS INC (JP) 2017-08-02 EP disclosed
EP-1007512-B1 BRANCHED ALKOXY-SUBSITUTED 2-AMINOPYRIDINES AS NOS INHIBITORS PFIZER PROD INC (US) 2002-04-03 EP disclosed
US-6362195-B1 INHIBITOR OF NITRIC OXIDE SYNTHASE; CENTRAL NERVOUS SYSTEM DISORDERS PFIZER INC. 2002-03-26 US disclosed
US-20020022642-A1 Branched alkoxy-subsituted 2-aminopyridines LOWE JOHN ADAMS (US) 2002-02-21 US disclosed
EP-1109556-A2 NEW PHARMACEUTICAL USES FOR NOS INHIBITORS Pfizer Products Inc. (US) 2001-06-27 EP disclosed
EP-1047670-A1 AMINOSULPHONYLBENZAMIDE DERIVATIVES AS MODULATORS OF THE ACTIVITY OF NEURONAL CALCIUM CHANNELS ELI LILLY AND COMPANY LIMITED (GB) 2000-11-02 EP disclosed
EP-1007512-A1 BRANCHED ALKOXY-SUBSITUTED 2-AMINOPYRIDINES AS NOS INHIBITORS Pfizer Products Inc. (US) 2000-06-14 EP disclosed
WO-2000009130-A2 NEW PHARMACEUTICAL USES FOR NOS INHIBITORS PFIZER PRODUCTS INC. (US) 2000-02-24 WO disclosed
WO-1999036398-A1 AMINOSULPHONYLBENZAMIDE DERIVATIVES AS MODULATORS OF THE ACTIVITY OF NEURONAL CALCIUM CHANNELS ELI LILLY AND COMPANY LIMITED (GB) 1999-07-22 WO disclosed
WO-1999011620-A1 BRANCHED ALKOXY-SUBSITUTED 2-AMINOPYRIDINES AS NOS INHIBITORS PFIZER PRODUCTS INC. (US) 1999-03-11 WO disclosed
EP-0769003-A1 AMINO ACID-DERIVED DIAMINOPROPANOLS Pharmeco Laboratories, Inc. (US) 1997-04-23 EP disclosed